Noval design of a Bi-Ventricular Assist Device (BVAD) Centrifugal Heart Pump as an Implantable Total Artificial Heart. In Australia, 40%(50,797) of all deaths each year are related to heart disease and accounted for 12% (A$4Billion) of total recurrent health expenditure. This innovative research aims at developing a single biventricular assist device (BVAD) driven by a magnetically suspended double-sided centrifugal pump impeller. Current techniques require two implantable devices, thus preventi ....Noval design of a Bi-Ventricular Assist Device (BVAD) Centrifugal Heart Pump as an Implantable Total Artificial Heart. In Australia, 40%(50,797) of all deaths each year are related to heart disease and accounted for 12% (A$4Billion) of total recurrent health expenditure. This innovative research aims at developing a single biventricular assist device (BVAD) driven by a magnetically suspended double-sided centrifugal pump impeller. Current techniques require two implantable devices, thus preventing smaller patients from access to BVAD technology. The expected outcomes will be a significantly small and compact device and provide an alternative to open-heart transplantation, thus helping to alleviate the demand on donor hearts, as well as the strain on the Australian Heath Care System caused by cardiovascular disease.Read moreRead less